Delivery Order SPE2DB20D3304-SPE2DB24FW7J9

Award Date 9/22/24
Potential Completion Date 9/23/24
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,158.74 firm fixed-price contract is for the supply of the medication Humira (adalimumab) in a prefilled pen form. The contract has a performance period through July 2024 and is not a set-aside. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for providing a wide range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Humira (adalimumab) pens. The $22,850.20 firm fixed-price contract has an ultimate completion date of August 20, 2024. AmerisourceBergen is delivering this product under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a wide range of medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,549.45, is for the delivery of Humira (adalimumab) prefilled pens for the U.S. government, with an ultimate completion date of October 26, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Humira (adalimumab) in a specialty injection pen format. The $33,306.55 firm fixed-price contract has a period of performance through November 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,770.74, is for the supply of Humira Pen, a specialty medication used in the treatment of various medical conditions. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 80 mg/0.8 mL pens. The contract has a ceiling value of $5,354.56 and a completion date of December 13, 2024. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira Pen 40 mg/0.8 ml. The contract has a ceiling value of $8,428.26 and is a firm fixed-price delivery order with a completion date of July 5, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for the supply of Humira (adalimumab) auto-injector pens. The contract is a firm-fixed price delivery order with a ceiling value of $1,847.20 and a period of performance through August 27, 2024. There is no set-aside designation for this award. Amerisourcebergen has a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) pens. The contract has a firm fixed price of $29,441.08 and a period of performance through April 26, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Humira Pen 40 mg/0.8 mL. The award is for a firm fixed price of $1,132.95 and has an ultimate completion date of January 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB24FW7J9
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Humira (adalimumab) in a prefilled pen device. The order is a firm fixed price contract valued at $8,494.90 with a period of performance through September 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which can be valued up to $999,999,999 through December 2025, for the provision of a wide range of pharmaceutical products and medical supplies to support military healthcare programs. The contract does not have a set-aside designation.

Generated 12/22/24, 9:02 AM